InvestorsHub Logo
Followers 41
Posts 3040
Boards Moderated 0
Alias Born 11/16/2015

Re: None

Sunday, 06/28/2020 5:19:01 PM

Sunday, June 28, 2020 5:19:01 PM

Post# of 721726
This is interesting:


iii) King's College London have been taking the European lead on a Dendritic Cell Vaccine DCVax-L which for a third of the Phase III trial patients saw several live more than 7 years and a mean of 42 months.


https://www.canceractive.com/article/alternative-brain-cancer-treatments-that-work

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News